PAVmed (PAVM) to Release Earnings on Tuesday

PAVmed (NASDAQ:PAVM) is expected to release its earnings data before the market opens on Tuesday, March 25th. Analysts expect PAVmed to post earnings of ($0.40) per share and revenue of $0.02 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

PAVmed Trading Up 5.6 %

Shares of PAVM stock opened at $0.81 on Monday. PAVmed has a 12 month low of $0.57 and a 12 month high of $2.84. The stock has a market cap of $8.97 million, a P/E ratio of -0.19 and a beta of 1.19. The company has a 50 day simple moving average of $0.69 and a two-hundred day simple moving average of $0.92.

Analyst Upgrades and Downgrades

Separately, Ascendiant Capital Markets decreased their target price on PAVmed from $21.00 to $19.00 and set a “buy” rating on the stock in a report on Monday, December 9th.

PAVmed Company Profile

PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.